Joseph Feczko, M.D. was until May, 2009, Senior Vice President and Chief Medical Officer  (CMO) of Pfizer Inc and member of the Executive Leadership Team with global responsibilities for all aspects of the company’s medical, regulatory and safety activities.  He is Board Certified (U.S.) in Internal Medicine and Infectious Diseases.  He is currently a member of the Board of Directors of the Foundation for the National Institutes of Health, and Research!America.  He is a member of the Board of Directors of the Accordia Global Health Foundation and a member of the Technical Expert Committee for Trachoma on the International Trachoma Initiative of the Task Force for Global Health.  He served as a member of the governing board of the Technology Strategy Board of the United Kingdom from 2006-2011.   In the field of Biotechnology he has the following appointments:  member of the Board of Directors of Keryx Biopharmaceuticals, Inc. (New York); a member of the Board of Directors of ChemoCentryx Inc (San Francisco);  and a member of the Supervisory Board of  uniQure, B.V. based in The Netherlands.

 Medicine and Infectious Diseases